---
figid: PMC8817698__ars.2021.0167_figure4
figtitle: MAVS Immune Recognition Pathway in Viral Infection and Sepsis
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8817698
filename: ars.2021.0167_figure4.jpg
figlink: /pmc/articles/PMC8817698/figure/f4/
number: F4
caption: Negative regulation of MAVS signaling by antagonistic viral proteins. Viruses
  attempt to escape the host antiviral immune response through the help of specialized
  proteins. Different evasion strategies occur, such as cleavage or proteasomal degradation
  of MAVS, or direct binding to the signaling molecules for blocking RLR pathways.
  The names of the proteins are shown in brackets after their encoding virus. EBOV,
  Ebola virus; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus;
  HIV-1, human immunodeficiency virus; hMPV, human metapneumovirus; HPIV, human parainfluenza
  viruses; HRVC, human rhinovirus C; IAV, influenza A virus; PRRSV, porcine reproductive
  and respiratory syndrome virus; RSV, respiratory syncytial virus; SARS-CoV and SARS-CoV-2,
  severe acute respiratory syndrome coronaviruses 1 and 2; SVV, Seneca valley virus.
  Color images are available online.
papertitle: The MAVS Immune Recognition Pathway in Viral Infection and Sepsis.
reftext: Arjun Sharma, et al. Antioxid Redox Signal.  December 2021;35(16):1376-1392.
year: '2021'
doi: 10.1089/ars.2021.0167
journal_title: Antioxidants & Redox Signaling
journal_nlm_ta: Antioxid Redox Signal
publisher_name: Mary Ann Liebert, Inc., publishers
keywords: VISA | IPS-1 | CARDIF | DDX58 | IFIH1 | reactive oxygen species | COVID-19
  | LGP2 | ARDS
automl_pathway: 0.9383788
figid_alias: PMC8817698__F4
figtype: Figure
redirect_from: /figures/PMC8817698__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8817698__ars.2021.0167_figure4.html
  '@type': Dataset
  description: Negative regulation of MAVS signaling by antagonistic viral proteins.
    Viruses attempt to escape the host antiviral immune response through the help
    of specialized proteins. Different evasion strategies occur, such as cleavage
    or proteasomal degradation of MAVS, or direct binding to the signaling molecules
    for blocking RLR pathways. The names of the proteins are shown in brackets after
    their encoding virus. EBOV, Ebola virus; HAV, hepatitis A virus; HBV, hepatitis
    B virus; HCV, hepatitis C virus; HIV-1, human immunodeficiency virus; hMPV, human
    metapneumovirus; HPIV, human parainfluenza viruses; HRVC, human rhinovirus C;
    IAV, influenza A virus; PRRSV, porcine reproductive and respiratory syndrome virus;
    RSV, respiratory syncytial virus; SARS-CoV and SARS-CoV-2, severe acute respiratory
    syndrome coronaviruses 1 and 2; SVV, Seneca valley virus. Color images are available
    online.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tm1
  - Ns2
  - Ns1
  - Glg1
  - a6
  - nAChRalpha6
  - Prosalpha6
  - Iru
  - Ns3
  - iav
  - nan
  - Traf6
  - Traf4
  - CG11700
  - rb
  - betaTub60D
  - Prosbeta3
  - bat
  - lolal
  - sev
  - MAVS
  - NECTIN1
  - NR1I2
  - ATP6AP2
  - HSF4
  - NS2
  - LZTR1
  - PTPN11
  - IVNS1ABP
  - ITIH4
  - KRAS
  - RIGI
  - IFIH1
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF4
  - TRAF5
  - TRAF6
  - TRAF7
  - EEF1B2P2
  - BHLHE22
  - BAAT
  - SH2D3A
  - NLRX1
  - GOLM1
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - OTUD1
---
